- Filed
- May 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · May 12, 2025 | 134.48M sh |
| Short Term Investments | FY 2025 · Mar 31, 2025 | $0 |
| Short Term Investments | FY 2025 · Mar 31, 2024 | $1.05M |
| Long Term Debt | FY 2025 · Mar 31, 2024 | $409.69M |
| Short Term Debt | FY 2025 · Mar 31, 2024 | $0 |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $172.58M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $654.02M |
| Current Assets | FY 2025 · Mar 31, 2024 | $247.84M |
| Total Assets | FY 2025 · Mar 31, 2024 | $755.98M |
| Shares Diluted | FY 2025 · Mar 31, 2023 | 115.96M sh |
| Stock Repurchased | FY 2025 · Mar 31, 2023 | $60.21M |
| Stock Repurchased | FY 2025 · Dec 31, 2021 | $45M |
| Capex | FY 2025 · Mar 31, 2023 | $2.99M |
| Operating Cash Flow | FY 2025 · Mar 31, 2023 | $48.79M |
| Cash And Equivalents | FY 2025 · Mar 31, 2023 | $111.4M |
| Eps Diluted | FY 2025 · Mar 31, 2023 | −$0.63 |
| Eps Basic | FY 2025 · Mar 31, 2023 | −$0.63 |
| Rd Expense restated | FY 2025 · Mar 31, 2023 | $142.49M |
| Net Income | FY 2025 · Mar 31, 2023 | −$73.14M |
| Operating Income | FY 2025 · Mar 31, 2023 | −$66.29M |
| Gross Profit | FY 2025 · Mar 31, 2023 | $502.46M |
| Cost Of Revenue | FY 2025 · Mar 31, 2023 | $241.48M |
| Revenue | FY 2025 · Mar 31, 2023 | $743.94M |
| Stockholders Equity | FY 2025 · Mar 31, 2022 | $182.37M |